Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.19.3.a.u2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2019
Mar. 31, 2019
Current assets    
Cash $ 33,714 $ 10,894
Restricted cash 165 165
Accounts receivable, net of allowances of $1,101 and $895, respectively 26,694 22,707
Prepaid expenses and other current assets 2,141 1,331
Current assets held for disposal 1,527 2,026
Total current assets 64,241 37,123
Property and equipment, net 5,116 3,430
Right-of-use assets 2,029  
Deferred tax assets 0 40
Goodwill 42,268 42,268
TOTAL ASSETS 113,654 82,861
Current liabilities    
Accounts payable 20,820 14,912
Accrued license fees and revenue share 16,264 16,205
Accrued compensation 3,296 2,441
Warrant liability 6,300 0
Other current liabilities 4,285 826
Current liabilities held for disposal 3,431 3,924
Total current liabilities 54,396 38,308
Warrant liability 0 8,013
Other non-current liabilities 2,007 182
Total liabilities 56,403 46,503
Stockholders' equity    
Preferred stock - Series A convertible preferred stock at $0.0001 par value; 2,000,000 shares authorized, 100,000 issued and outstanding (liquidation preference of $1,000) 100 100
Common stock - $0.0001 par value: 200,000,000 shares authorized; 87,057,421 issued and 86,322,965 outstanding at December 31, 2019; 82,354,940 issued and 81,620,485 outstanding at March 31, 2019 10 10
Additional paid-in capital 353,968 332,793
Treasury stock (754,599 shares at December 31, 2019 and March 31, 2019) (71) (71)
Accumulated other comprehensive loss (720) (356)
Accumulated deficit (296,036) (296,118)
Total stockholders' equity 57,251 36,358
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 113,654 $ 82,861